✦ LIBER ✦

Role of hemostatic defect during thrombolytic therapy with recombinant tissue-type plasminogen activator

✍ Scribed by D.C. Stump

Book ID: 119037905
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 26 KB
Volume: 57
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(90)90381-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Laboratory monitoring of hemostasis duri

Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator

✍ H.D Garabedian; H.K Gold; R.C Leinbach; T Yasuda; J.A Johns; D Thornton; D Colle 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 936 KB

Bleeding complications during the early

Bleeding complications during the early phase of thrombolytic therapy with tissue-type plasminogen activator

✍ M. Brunner; W. Schreiber; M. Zehender; A N Laggner 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 67 KB

Peripheral arterial occlusions: Local lo

Peripheral arterial occlusions: Local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA)

✍ H. Hess; A. Mietaschk; P. von Bilderling; P. Neller 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Thrombolytic therapy with tissue-type pl

Thrombolytic therapy with tissue-type plasminogen activator: New modes and novel variant plasminogen activators

✍ Glenn R. Larsen; Elliot S. Barnathan 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 846 KB

Tissue-type plasminogen activator produced by recombinant DNA technology, has been established as an important thrombolytic agent in the treatment of acute myocardial infarction. New approaches to increase the effectiveness of this agent, including rapid high dose administration are being investigat

Recombinant tissue-type plasminogen acti

Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates

✍ Caroline Farnoux; Odile Camard; Didier Pinquier; Marie-Françoise Hurtaud-Roux; G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 127 KB

An ultrasound-responsive nano delivery s

An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy

✍ Yoshiko Uesugi; Hiroyuki Kawata; Jun-ichiro Jo; Yoshihiko Saito; Yasuhiko Tabata 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 596 KB